Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Multi-Center Phase I Dose-Escalation Study With Lenalidomide In Patients With Acute Myeloid Leukemia

NCT00839059 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT00839059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00839059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Multi-Center Phase I Dose-Escalation Study With Lenalidomide In Patients With Acute Myeloid Leukemia
Lead sponsor
University of Ulm
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2009
Completion date
May 31, 2011
Enrollment
14 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia